Dr. Xiaoxi Wei is an award-winning American entrepreneur and inventor renowned for her groundbreaking work in biomimetic nanoscience and biopreservation. Driven by a vision to enable "on-demand"organs, tissues, and cell products, she completed her Ph.D. in Biomimetic Chemistry at SUNY Buffalo, where she successfully managed $8 million in engineering projects. In 2014, Dr. Wei founded X-Therma Inc., a venture-backed biotech company in the San Francisco Bay Area, to translate laboratory innovations into patient care for accessing on-demand regenerative medicines. Her pioneering inventions have led to over 20 issued global patents in biomimetic materials and devices for subzero, ice-preventing preservation, earning an FDA Breakthrough Device designation in human kidney transplantation in 2022. Dr. Wei has served as Principal Investigator (PI) or co-PI on 12 national and international innovation research grants, securing over $14 million from prestigious organizations such as the DoD, NSF, NIH, CIRM, and the EU. She is a healthcare advisor for the UC Regents working group on innovation transfer and entrepreneurship, a scientific advisor for the Life Extension Foundation, and has held leadership roles within the American Chemical Society (ACS), including Vice Chair of the Younger Chemists Committee and member of the Cal ACS Executive Committee. Currently, she is a distinguished member of the RULEBREAKER Society in Germany.